⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Vocense Inc. and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Vocense Inc.
↗San Antonio, USA
Vocense Inc. is an emerging medical technology company specializing in the development of non-invasive diagnostic devices for chronic and serious wounds. The company is actively working on olfactory biosensor technology designed to detect pathogenic bacteria and analyze wound odors in real-time to improve clinical decision-making in wound care.
The company maintains a research-oriented profile, collaborating with academic and clinical institutions such as the University Hospitals Coventry and Warwickshire NHS Trust. Their work focuses on bridging the gap between traditional wound microbiology and advanced biosensor data to enhance the treatment of complex surgical and chronic wounds.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Ownership:private
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Clinical feasibility study (OBOWE 2)
Modalities:Medical Device, Digital Health
Active Trials:1
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:University Hospitals Coventry and Warwickshire NHS Trust (Clinical research collaboration for OBOWE 2 study)
COMPETITION
Position:Emerging
LINKS
Website:vocense.com
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Vocense Inc.. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.